Larimar Therapeutics Ownership | Who Owns Larimar Therapeutics?


OverviewForecastFinancialsChartTranscripts

Larimar Therapeutics Ownership Summary


Larimar Therapeutics is owned by 31.37% institutional investors, 1.10% insiders, and 67.53% retail investors. Deerfield management company, l.p. (series c) is the largest institutional shareholder, holding 47.80% of LRMR shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.10% of its assets in Larimar Therapeutics shares.

LRMR Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockLarimar Therapeutics31.37%1.10%67.53%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustryBiotech Stocks 381.47%10.55%-292.02%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Deerfield management company, l.p. (series c)30.61M47.80%$98.86M
Ra capital management6.05M9.44%$19.53M
Blue owl capital lp6.82M8.71%$26.00M
Blackrock3.13M5.85%$22.72M
Opaleye management3.72M5.81%$10.56M
Rtw investments, lp3.13M4.88%$10.09M
Blackrock funding, inc. /de3.68M4.70%$14.03M
Vanguard group3.05M3.89%$11.61M
Adage capital partners gp1.90M2.97%$6.14M
Alyeska investment group1.89M2.95%$6.10M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Blue owl capital lp6.82M1.95%$26.00M
Aigh capital management2.00M1.84%$7.62M
Deerfield management company, l.p. (series c)30.61M1.51%$98.86M
Opaleye management3.72M1.49%$10.56M
Dafna capital management1.03M0.82%$3.32M
Altium capital management lp505.00K0.55%$1.95M
Ra capital management6.05M0.24%$19.53M
Sphera funds management260.38K0.18%$841.04K
Rtw investments, lp3.13M0.12%$10.09M
Mangrove partners442.24K0.11%$1.43M

Top Buyers

HolderShares% AssetsChange
Deerfield management company, l.p. (series c)30.61M1.51%9.38M
Rtw investments, lp3.13M0.12%3.13M
Adage capital partners gp1.90M0.01%1.90M
Point72 asset management1.22M0.01%1.22M
Woodline partners lp1.62M0.02%1.00M

Top Sellers

HolderShares% AssetsChange
Janus henderson group---5.57M
Two sigma advisers, lp252.37K0.00%-894.55K
Two sigma investments, lp134.73K0.00%-768.88K
Fred alger management---737.55K
Stempoint capital lp---704.35K

New Positions

HolderShares% AssetsChangeValue
Rtw investments, lp3.13M0.12%3.13M$10.09M
Adage capital partners gp1.90M0.01%1.90M$6.14M
Point72 asset management1.22M0.01%1.22M$3.95M
Hap trading262.78K0.06%262.78K$848.77M
Hap trading237.78K0.07%237.78K$687.17K

Sold Out

HolderChange
National bank of canada /fi/-2.00
Larson financial group-4.00
Nelson, van denburg & campbell wealth management group-5.00
Quadrant capital group-14.00
Capital performance advisors llp-18.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202591-40.91%24,571,182-71.27%310.18%39-58.06%3114.81%
Sep 30, 202514724.58%83,602,86738.89%1301.47%8722.54%2623.81%
Jun 30, 202512418.10%62,303,7192.43%971.08%7250.00%24-22.58%
Mar 31, 202510-91.80%31,178,885-50.84%480.49%5-92.19%1-97.14%
Dec 31, 2024116-8.66%61,296,513-4.71%960.95%61-6.15%32-5.88%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF1.34M2.10%-
Vanguard Total Stock Mkt Idx Inv1.95M1.83%-
iShares Russell 2000 ETF1.20M1.14%1.20M
Fidelity Advisor Biotechnology I524.80K0.82%-
Invesco Dorsey Wright SmallCap Momt ETF422.53K0.66%-
Alger Small Cap Growth B398.96K0.62%-
Heptagon Driehaus US Micro Cap Eq C$ Acc387.15K0.61%-2.69K
iShares Russell 2000 Growth ETF388.03K0.61%-
Janus Henderson Hrzn Biotec E2 USD347.56K0.54%-107.54K
Fidelity Small Cap Index488.54K0.46%18.51K

Recent Insider Transactions


DateNameRoleActivityValue
Feb 27, 2026Flynn James E * Director by DeputizationBuy$4.16M
Feb 27, 2026Flynn James E * Director by DeputizationBuy$10.00M
Feb 27, 2026Flynn James E * Director by DeputizationBuy$5.42M
Feb 27, 2026Flynn James E * Director by DeputizationBuy$5.42M
Feb 27, 2026Hamilton Thomas Edward-Buy$500.00K

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q33-
2025 Q2--
2025 Q1--
2024 Q2--

LRMR Ownership FAQ


Who Owns Larimar Therapeutics?

Larimar Therapeutics shareholders are primarily institutional investors at 31.37%, followed by 1.10% insiders and 67.53% retail investors. The average institutional ownership in Larimar Therapeutics's industry, Biotech Stocks , is 381.47%, which Larimar Therapeutics falls below.

Who owns the most shares of Larimar Therapeutics?

Larimar Therapeutics’s largest shareholders are Deerfield management company, l.p. (series c) (30.61M shares, 47.80%), Ra capital management (6.05M shares, 9.44%), and Blue owl capital lp (6.82M shares, 8.71%). Together, they hold 65.96% of Larimar Therapeutics’s total shares outstanding.

Does Blackrock own Larimar Therapeutics?

Yes, BlackRock owns 5.85% of Larimar Therapeutics, totaling 3.13M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 22.72M$. In the last quarter, BlackRock increased its holdings by 795.19K shares, a 34.00% change.

Who is Larimar Therapeutics’s biggest shareholder by percentage of total assets invested?

Blue owl capital lp is Larimar Therapeutics’s biggest shareholder by percentage of total assets invested, with 1.95% of its assets in 6.82M Larimar Therapeutics shares, valued at 26M$.

Who is the top mutual fund holder of Larimar Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Larimar Therapeutics shares, with 2.10% of its total shares outstanding invested in 1.34M Larimar Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools